Tag archive for ‘Toxicology’
Niva Goldberg On Sunday, July 26th, 2015

Three Way Takeover Battle: Teva set to buy Allergan’s generics unit – WSJ

Teva likely mean the end of Teva’s pursuit of another Teva Pharmaceutical Industries Ltd. likely mean the end of pursuit of Mylan acquisition. The Israeli world’s biggest generic pharmaceutical maker More...

Niva Goldberg On Wednesday, June 17th, 2015

Botox maker pays $2.1 billion for double-chin treatment

  Allergan PLC, the Botox maker to treat wrinkles, agreed to buy Kythera Biopharmaceuticals Inc., which focus on the aesthetic medicine market, for about $2.1 billion in cash and equity transaction More...

Vered Weiss On Monday, March 9th, 2015

What Plans Does Bill Ackman Have for Valeant with his $3.3 Billion Stake?

Pershing Square’s Bill Ackman didn’t manage to make Valeant into a successful hunter, so one wonders, with his $3.3 billion stake, as reported by Reuters, will he make Valeant, like he did Allergan, More...

Vered Weiss On Thursday, February 12th, 2015

Allergan CEO Says Fighting Off Activist Bill Ackman Was Full Time Job

One thing Allergan CEO David Pyott enjoyed doing was running his company. When activist investor Bill Ackman of Pershing Square decided to have Valeant Pharmaceuticals try to swallow up the Botox maker in a More...

Wordpress site Developed by Fixing WordPress Problems